The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a public knowledgebase to facilitate decision support for clinical cancer genomics reporting and clinical trial enrollment.
 
Kenna Rael Shaw
No Relationships to Disclose
 
Jia Zeng
No Relationships to Disclose
 
Ann Marie Bailey
No Relationships to Disclose
 
Amber Johnson
No Relationships to Disclose
 
Beate Litzenburger
No Relationships to Disclose
 
Vijaykumar Holla
No Relationships to Disclose
 
Elmer Victor Bernstam
Honoraria - Genetic Technologies (I); Roche Pharma AG (I); Sysmex (I)
Consulting or Advisory Role - Novartis (I); Roche Pharma AG (I)
Research Funding - AstraZeneca (I); Bayer (I); Calithera Biosciences (I); Debiopharm Group (I); Genentech (I); Novartis (I); Taiho Pharmaceutical (I)
Other Relationship - Genentech (I); Novartis (I); Roche Pharma AG (I)
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; PTV Sciences; Spindletop Ventures
Consulting or Advisory Role - AstraZeneca; Blend Therapeutics; Critical OUtcome Technologies; HanAl Bio Korea; Illumina; Life Science Pharmaceuticals; Nuevolution; Pfizer; Provista Diagnostics; Roche Pharma AG; SignalChem; Symphony Evolution; Tau Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Critical Outcome Technologies; GlaxoSmithKline; Illumina
 
John Mendelsohn
Leadership - Merrimack
Consulting or Advisory Role - Capital Royalty
Patents, Royalties, Other Intellectual Property - UCSD/IMCLONE
 
Mark Routbort
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical